The rise and fall of NMDA antagonists for ischemic stroke.
It has long been accepted that high concentrations of glutamate can destroy neurons, and this is the basis of the theory of excitotoxicity during brain injury such as stroke. Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists such as Selfotel, Aptiganel, Gavestinel and others failed to show...
Հիմնական հեղինակներ: | Hoyte, L, Barber, P, Buchan, A, Hill, MD |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2004
|
Նմանատիպ նյութեր
-
NMDA antagonists: their role in neuroprotection.
: Small, D, և այլն
Հրապարակվել է: (1997) -
NMDA antagonists: their role in neuroprotection.
: Small, D, և այլն
Հրապարակվել է: (1997) -
Do NMDA antagonists prevent neuronal injury? No.
: Buchan, A
Հրապարակվել է: (1992) -
AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
: Buchan, A, և այլն
Հրապարակվել է: (1993) -
The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
: Buchan, A, և այլն
Հրապարակվել է: (1992)